GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (MEX:COO) » Definitions » Debt-to-Asset

The Cooper (MEX:COO) Debt-to-Asset : 0.21 (As of Oct. 2024)


View and export this data going back to 2014. Start your Free Trial

What is The Cooper Debt-to-Asset?

The Cooper's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2024 was MXN667 Mil. The Cooper's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2024 was MXN51,088 Mil. The Cooper's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Oct. 2024 was MXN246,691 Mil. The Cooper's debt to asset for the quarter that ended in Oct. 2024 was 0.21.


The Cooper Debt-to-Asset Historical Data

The historical data trend for The Cooper's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Debt-to-Asset Chart

The Cooper Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.15 0.24 0.22 0.21

The Cooper Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.23 0.23 0.22 0.21

Competitive Comparison of The Cooper's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, The Cooper's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cooper's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where The Cooper's Debt-to-Asset falls into.



The Cooper Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

The Cooper's Debt-to-Asset for the fiscal year that ended in Oct. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(667.046 + 51088.083) / 246690.697
=0.21

The Cooper's Debt-to-Asset for the quarter that ended in Oct. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(667.046 + 51088.083) / 246690.697
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Cooper  (MEX:COO) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


The Cooper Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of The Cooper's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cooper Business Description

Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.